In recent years, imaging tumors with receptor-specific biomolecules has been the focus of increasing interest. Vasoactive intestinal peptide (VIP)(VPAC) has a high affinity for specific receptors that are expressed in high density on many malignant tumors.
99mTcLabeled Vasoactive Intestinal Peptide Analog for Rapid Localization of Tumors in Humans
Recommended For You
Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics
Karla Jo HelmsFebruary 28, 2021
VIP/PACAP, and their receptors and cancer
Karla Jo HelmsMay 28, 2020
